Abstract
TRANSCRIPTION factor IIH (TFIIH) contains a kinase capable of phosphorylating the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II (RNAPII)1–3. Here we report the identification of the Cdk-activating kinase (Cak) complex (Cdk7 and cyclin H) as a component of TFIIH after extensive purification of TFIIH by chromatography. We find that affinity-purified antibodies directed against cyclin H inhibit TFIIH-dependent transcription and that both cyclin H and Cdk7 antibodies inhibit phosphorylation of the CTD of the largest subunit of the RNAPII in the preinitiation complex. Cak is present in at least two distinct complexes, TFIIH and a smaller complex that is unable to phosphorylate RNAPII in the preinitiation complex. Both Cak complexes, as well as recombinant Cak, phosphorylate a CTD peptide. Finally, TFIIH was shown to phosphorylate both Cdc2 and Cdk2, suggesting that there could be a link between transcription and the cell cycle machinery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lu H., Zawel, L., Fisher, L., Egly, J. M. & Reinberg, D. Nature 358, 641–645 (1992).
Feaver, W. J., Gileadi, O., Li, Y. & Kornberg, R. D. Cell 67, 1223–1230 (1991).
Serizawa, H., Conaway, R. C. & Conaway, J. W. Proc. natn. Acad. Sci. U.S.A. 89, 7476–7460 (1992).
Cisek, L. J. & Corden, J. L. Nature 339, 679–684 (1989).
Cisek, L. J. & Corden, J. L. Meth. Enzym. 200, 301–325 (1991).
Zawel, L., Lu, H., Cisek, L. J., Corden, J. L. & Reinberg, D. Cold Spring Harbor Symp. quant. Biol. 58, 187–198 (1993).
Makela, T. P. et al. Nature 371, 254–257 (1994).
Fisher, R. P. & Morgan, D. O. Cell 78, 713–724 (1994).
Lu, H., Flores, O., Weinmann, R. & Reinberg, D. Proc. natn. Acad. Sci. U.S.A. 88, 10004–10008 (1991).
Drapkin, R. et al. Nature 368, 769–772 (1994).
Van Vuuren, A. J. et al. EMBO J. 13, 1645–1653 (1994).
Wang, Z. et al. Nature 368, 74–75 (1994).
Harlow, E. & Lane, D. Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1988).
Dignam, D. J., Lebowitz, R. M. & Roeder, R. G. Nucleic Acids Res. 11, 1475–1485 (1983).
Flores, O., Lu, H. & Reinberg, D. J. biol. Chem. 267, 2786–2793 (1992).
Roy, R. et al. Cell 79, 1093–1101 (1994).
Feaver, W. J., Svejstrup, J. Q., Henry, N. L. & Kornberg, R. D. Cell 79, 1103–1109 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shiekhattar, R., Mermelstein, F., Fisher, R. et al. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374, 283–287 (1995). https://doi.org/10.1038/374283a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/374283a0
This article is cited by
-
Cyclin-dependent kinase 7 (CDK7) inhibitors as a novel therapeutic strategy for different molecular types of breast cancer
British Journal of Cancer (2024)
-
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
British Journal of Cancer (2023)
-
Discovery and resistance mechanism of a selective CDK12 degrader
Nature Chemical Biology (2021)
-
Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
Cancer Cell International (2020)
-
ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942
Oncogene (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
